arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BillionToOne, Inc.

BLLN
$114.39 ▼ -1.55 (-1.34%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
11 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

BillionToOne, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.3B
Dividend Yield
Revenue Growth 64.4%
Op. Margin 5.0%
ROIC 0.9%
FCF / Share $0.11
Trailing P/E 672.9x
Price / Book 9.9x
FCF Yield 0.1%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Sep 23, 2026.

11-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$109.45M
↑ +64.4%
Net Income Profit after all expenses
$8.05M
↓ -55.2%
Operating Margin Operating profit as % of sales
5.0%
↓ -69.4% 43th
FCF / Share Free cash flow per share
$0.11
↓ -54.1%
Long-Term Debt Long-term obligations
$91.03M
↑ +1.1%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
43
Returns
47
Financial Health
74
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 11 quarters